CL2025001049A1 - Sistema de administración de ingrediente activo - Google Patents

Sistema de administración de ingrediente activo

Info

Publication number
CL2025001049A1
CL2025001049A1 CL2025001049A CL2025001049A CL2025001049A1 CL 2025001049 A1 CL2025001049 A1 CL 2025001049A1 CL 2025001049 A CL2025001049 A CL 2025001049A CL 2025001049 A CL2025001049 A CL 2025001049A CL 2025001049 A1 CL2025001049 A1 CL 2025001049A1
Authority
CL
Chile
Prior art keywords
active ingredient
delivery system
ingredient delivery
optionally
user
Prior art date
Application number
CL2025001049A
Other languages
English (en)
Inventor
JÄRVENPÄÄ Janne
Original Assignee
Opes Corp Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=83690055&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2025001049(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Opes Corp Oy filed Critical Opes Corp Oy
Publication of CL2025001049A1 publication Critical patent/CL2025001049A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
    • A24B15/32—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances by acyclic compounds
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B13/00—Tobacco for pipes, for cigars, e.g. cigar inserts, or for cigarettes; Chewing tobacco; Snuff
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/24—Treatment of tobacco products or tobacco substitutes by extraction; Tobacco extracts
    • A24B15/241—Extraction of specific substances
    • A24B15/243—Nicotine
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
    • A24B15/302—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances by natural substances obtained from animals or plants
    • A24B15/303—Plant extracts other than tobacco
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
    • A24B15/308—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances vitamins
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B3/00—Preparing tobacco in the factory
    • A24B3/14—Forming reconstituted tobacco products, e.g. wrapper materials, sheets, imitation leaves, rods, cakes; Forms of such products
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physiology (AREA)
  • Toxicology (AREA)
  • Nutrition Science (AREA)
  • Botany (AREA)
  • Agronomy & Crop Science (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Zoology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Seasonings (AREA)
  • Confectionery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Manufacture Of Tobacco Products (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Un sistema de administración de ingrediente activo y un método para fabricarlo. El sistema puede incluir una matriz dispuesta sobre un sustrato. La matriz incluye un componente de ingrediente activo farmacéutico, un portador y, opcionalmente, un componente de sabor y, opcionalmente, componentes adicionales. El sistema de administración de ingrediente activo puede proporcionar un ingrediente activo a un usuario mediante absorción en las encías del usuario.
CL2025001049A 2021-09-20 2025-04-08 Sistema de administración de ingrediente activo CL2025001049A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US202163246089P 2021-09-20 2021-09-20

Publications (1)

Publication Number Publication Date
CL2025001049A1 true CL2025001049A1 (es) 2025-08-08

Family

ID=83690055

Family Applications (3)

Application Number Title Priority Date Filing Date
CL2024000812A CL2024000812A1 (es) 2021-09-20 2024-03-19 Sistema de administración de principios activos.
CL2025001049A CL2025001049A1 (es) 2021-09-20 2025-04-08 Sistema de administración de ingrediente activo
CL2025001048A CL2025001048A1 (es) 2021-09-20 2025-04-08 Sistema de administración de ingrediente activo

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CL2024000812A CL2024000812A1 (es) 2021-09-20 2024-03-19 Sistema de administración de principios activos.

Family Applications After (1)

Application Number Title Priority Date Filing Date
CL2025001048A CL2025001048A1 (es) 2021-09-20 2025-04-08 Sistema de administración de ingrediente activo

Country Status (22)

Country Link
US (1) US20240269087A1 (es)
EP (2) EP4537678A1 (es)
JP (2) JP7710264B2 (es)
KR (1) KR20240072188A (es)
CN (1) CN118201503A (es)
AU (3) AU2022346938B2 (es)
CA (1) CA3232535A1 (es)
CL (3) CL2024000812A1 (es)
DK (1) DK4404774T3 (es)
ES (1) ES3030034T3 (es)
FI (1) FI4404774T3 (es)
HR (1) HRP20250464T1 (es)
HU (1) HUE071598T2 (es)
IL (1) IL311530A (es)
LT (1) LT4404774T (es)
MA (1) MA64901A1 (es)
MX (1) MX2024003414A (es)
PL (1) PL4404774T3 (es)
PT (1) PT4404774T (es)
RS (1) RS66724B1 (es)
SI (1) SI4404774T1 (es)
WO (1) WO2023041848A1 (es)

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4800903A (en) * 1985-05-24 1989-01-31 Ray Jon P Nicotine dispenser with polymeric reservoir of nicotine
US6136297A (en) * 1997-06-06 2000-10-24 The Procter & Gamble Company Delivery system for an oral care substance using a strip of material having low flexural stiffness
JP2000319167A (ja) * 1999-05-12 2000-11-21 Nitto Denko Corp 口腔内貼付シート
US6514484B2 (en) * 2001-03-19 2003-02-04 The Procter & Gamble Company Systems for delivering a cosmetic and/or therapeutic active to oral surfaces using an integral carrier
SI1617823T1 (sl) * 2003-01-24 2019-07-31 Nicachet Ab Vrečka, ki obsega nikotinski sestavek za transmukozno dajanje
SE0301244D0 (sv) 2003-04-29 2003-04-29 Swedish Match North Europe Ab Smokeless tobacco product user package
US20050066463A1 (en) 2003-09-25 2005-03-31 Brunner Michael S. Substrates and devices for applying a lip care formulation
CN104397869B (zh) * 2003-11-07 2016-06-08 美国无烟烟草有限责任公司 烟草组合物
SE0402258D0 (sv) * 2004-05-07 2004-09-17 Katarina Saend Portionssnus
US20070218114A1 (en) * 2004-06-12 2007-09-20 Passionfor Life Healthcare Limited Soluble Strip for Oral or Topical Administration
US9044049B2 (en) 2005-04-29 2015-06-02 Philip Morris Usa Inc. Tobacco pouch product
GB0700889D0 (en) * 2007-01-17 2007-02-21 British American Tobacco Co Tobacco, tobacco derivative and/or tobacco substitute products, preparation and uses thereof
DE102008014533A1 (de) * 2008-03-15 2009-09-17 Lts Lohmann Therapie-Systeme Ag Gingival-Wafer
US9027567B2 (en) * 2008-12-30 2015-05-12 Philip Morris Usa Inc. Oral pouch product with multi-layered pouch wrapper
US20100256197A1 (en) * 2009-04-02 2010-10-07 Silver Eagle Labs Nv, Llc Nicotine Dissolving Film With Or Without Menthol
US8747562B2 (en) * 2009-10-09 2014-06-10 Philip Morris Usa Inc. Tobacco-free pouched product containing flavor beads providing immediate and long lasting flavor release
EP2600740A2 (en) * 2010-08-05 2013-06-12 Altria Client Services Inc. Fabric having tobacco entangled with structural fibers
WO2013104826A1 (en) 2012-01-11 2013-07-18 Ka Aroma Marketing Oy Scented preparation comprising scented compound
CN102754907B (zh) * 2012-01-20 2015-06-24 奥驰亚客户服务公司 口腔用产品
US20140255452A1 (en) * 2013-03-11 2014-09-11 Niconovum Usa, Inc. Method and apparatus for differentiating oral pouch products
WO2014150967A1 (en) * 2013-03-15 2014-09-25 Altria Client Services Inc. Oral energy products including encapsulated caffeine
US20160101108A1 (en) * 2013-05-23 2016-04-14 Åbo Akademi University Printed dosage forms
WO2014198999A1 (en) 2013-06-13 2014-12-18 Opes Corporation Oy Matrix
US20160192703A1 (en) * 2015-01-07 2016-07-07 R.J. Reynolds Tobacco Company Oral pouch products
US20160250270A1 (en) * 2015-02-27 2016-09-01 Ebbu, LLC Compositions comprising combinations of purified cannabinoids, with at least one flavonoid, terpene, or mineral
DK3192380T3 (da) * 2016-01-12 2021-01-18 Swedish Match North Europe Ab Oralt poseforpakket produkt
CN111212576A (zh) * 2017-06-26 2020-05-29 纳德尼古丁公司 烟碱盐及其制备和使用方法
CN107874324A (zh) * 2018-01-07 2018-04-06 张宇 一种尼古丁纸质纤维素载体及制作方法
KR101998288B1 (ko) * 2018-03-09 2019-07-09 (주)씨엘팜 무연 담배용 조성물 및 이를 포함하는 구강 용해 필름형 무연 담배
DE102019117310A1 (de) * 2019-06-27 2020-12-31 Lts Lohmann Therapie-Systeme Ag Verfahren zur Herstellung von Wirkstoffverabreichungssystemen mittels Tampondruckverfahren
WO2021045753A1 (en) 2019-09-04 2021-03-11 Vitiprints, LLC Printed delivery device having supplements
RU2745039C1 (ru) * 2019-11-22 2021-03-18 Кирилл Вадимович Альтшуллер Никотинсодержащая съедобная бумага
AU2020400347A1 (en) 2019-12-09 2022-07-07 Nicoventures Trading Limited Layered fleece for pouched product
EP4106556A1 (en) * 2020-02-18 2022-12-28 Nerudia Limited Smokeless article
EP3874970A1 (en) * 2020-03-03 2021-09-08 Reemtsma Cigarettenfabriken GmbH Filling material for an oral pouched smokeless product and oral pouched smokeless product manufactured therefrom

Also Published As

Publication number Publication date
JP7710264B2 (ja) 2025-07-18
LT4404774T (lt) 2025-05-12
FI4404774T3 (fi) 2025-05-06
DK4404774T3 (da) 2025-04-07
CL2024000812A1 (es) 2024-11-22
EP4404774B1 (en) 2025-02-12
PL4404774T3 (pl) 2025-06-16
IL311530A (en) 2024-05-01
HRP20250464T1 (hr) 2025-06-06
ES3030034T3 (en) 2025-06-26
CL2025001048A1 (es) 2025-08-08
EP4537678A1 (en) 2025-04-16
KR20240072188A (ko) 2024-05-23
RS66724B1 (sr) 2025-05-30
SI4404774T1 (sl) 2025-06-30
CN118201503A (zh) 2024-06-14
WO2023041848A1 (en) 2023-03-23
AU2022346938A1 (en) 2024-04-11
HUE071598T2 (hu) 2025-09-28
CA3232535A1 (en) 2023-03-23
US20240269087A1 (en) 2024-08-15
PT4404774T (pt) 2025-04-14
AU2025213655A1 (en) 2025-08-28
MA64901A1 (fr) 2024-11-29
JP2024535059A (ja) 2024-09-26
AU2025213645A1 (en) 2025-08-28
AU2022346938B2 (en) 2025-05-29
JP2025122079A (ja) 2025-08-20
MX2024003414A (es) 2024-05-10
EP4404774A1 (en) 2024-07-31

Similar Documents

Publication Publication Date Title
AR048705A1 (es) Composiciones farmaceuticas para el tratamiento de los trastornos sexuales ii
AR059097A1 (es) Tratamiento a largo plazo de la infeccion por vih
ES2376043T3 (es) Derivados de indazol para el tratamiento de enfermedades inducidas por hsp90.
AR059359A1 (es) Formulaciones farmaceuticas que contienen pleconaril
AR025329A1 (es) Tratamiento medicamentoso del sindrome de piernas inquietas
AR033423A1 (es) Sales farmaceuticas constituidas de una sustancia activa farmaceutica y al menos un edulcorante, medicamentos que contienen estas sales y uso de estas sales para la preparacion de medicamentos
CL2011000170A1 (es) Composicion farmaceutica solida y estabilizada que comprende un ingrediente farmaceuticamente activo, oxido de titanio y un plastificante; procedimiento para estabilizar la composicion farmaceutica durante una irradiacion luminosa.
NO20071914L (no) Kontrollert avleveringssystem
AR057180A1 (es) Formulacion farmaceutica de absorcion oral que comprende insulina, entre otros, y su metodo de administracion
AR044248A1 (es) Agentes para combatir parasitos en animales
CL2013002700A1 (es) Cápsula suave ingerible que contiene inositol y excipientes, o inositol, excipientes y al menos un principio activo adicional, tal como ácido fólico, polifenoles de cocoa, genisteína, l-arginina, vitamina e, selenio, n-acetilcisteína y melatonina; útil para el tratamiento del ovario poliquístico, resistencia a la insulina y otros
UY29561A1 (es) Derivados de quinazolina, composiciones farmacéuticas que los contienen, procedimientos de preparación y aplicaciones
CL2022003512A1 (es) Formas farmacéuticas osmóticas que comprenden deutetrabenazina y métodos de uso de las mismas
WO2008128191A3 (en) Oral cephalotaxine dosage forms
MX2016012319A (es) Formulaciones antihelminticas veterinarias estables.
AR057745A1 (es) Formulaciones de disoluciones de hfc que contienen hidrocloruro de salbutamol o citrato de salbutamol
EA200901148A1 (ru) Подкожные имплантаты, высвобождающие активные компоненты в течение длительного периода времени
AR062779A1 (es) Tratamiento de la esclerosis multiple (em)
CL2025001048A1 (es) Sistema de administración de ingrediente activo
ECSP109871A (es) Soluciones farmacéuticas orales que contienen telbivudina
AR033596A1 (es) Composicion farmaceutica para inyeccion intramuscular que contiene loxoprofeno
ES2325291A1 (es) "uso de un extracto de silybum marianum"
AR053780A1 (es) Uso de mirtazapina s para la fabricacion de un medicamento para el tratamiento de los bochornos
CL2021002373A1 (es) Fármaco y método para tratar o prevenir las complicaciones de la diabetes utilizando dicho fármaco
AR108632A1 (es) Botón para un dispositivo de administración de fármacos y método para ensamblar un botón para un dispositivo de administración de fármacos